Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given ...

Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to pose a significant global health challenge ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

Encompass Health tapped Patrick Tuer to serve as its first COO. He has held various leadership positions, including group ...

Two international academic journals have found that it is effective to apply classical treatments to patients with advanced ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...

Researchers have found in a new cohort study that the use of statins in patients with chronic liver disease was associated ...